PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Cardiovascular effects of Hodgkin's lymphoma: a review of literature.

Abstract Hodgkin's lymphoma (HL) constitutes 0.6% of all the cancers diagnosed worldwide and 10% of all lymphomas. Ten-year survival rate for HL is estimated to be 80% and cardiovascular death is the prevalent cause for a non-malignant death among these HL survivors. We are reviewing the cardiovascular morbidities associated with Hodgkin's lymphoma from the available literature. We performed a systematic review of all articles published from January 1, 1960 to October 1, 2016 on the MEDLINE database using PubMed search engine. Key factors in the diagnosis and management of these conditions are discussed in individual sections.
PMID
Related Publications

Late effects of Hodgkin's disease and its treatment.

State-of-the-art issues in Hodgkin's lymphoma survivorship.

The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.

Long-term complications in Hodgkin's lymphoma survivors.

Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.

Authors

Mayor MeshTerms
Keywords

Cancer

Cardiac

Cardiology

Cardiovascular

Chemotherapy

Complications

Hodgkin’s lymphoma

Lymphoma

Malignancy

Radiation

Treatment

Journal Title journal of cancer research and clinical oncology
Publication Year Start




PMID- 29255934
OWN - NLM
STAT- MEDLINE
DCOM- 20180109
LR  - 20180111
IS  - 1432-1335 (Electronic)
IS  - 0171-5216 (Linking)
VI  - 144
IP  - 1
DP  - 2018 Jan
TI  - Cardiovascular effects of Hodgkin's lymphoma: a review of literature.
PG  - 99-107
LID - 10.1007/s00432-017-2560-x [doi]
AB  - Hodgkin's lymphoma (HL) constitutes 0.6% of all the cancers diagnosed worldwide
      and 10% of all lymphomas. Ten-year survival rate for HL is estimated to be 80%
      and cardiovascular death is the prevalent cause for a non-malignant death among
      these HL survivors. We are reviewing the cardiovascular morbidities associated
      with Hodgkin's lymphoma from the available literature. We performed a systematic 
      review of all articles published from January 1, 1960 to October 1, 2016 on the
      MEDLINE database using PubMed search engine. Key factors in the diagnosis and
      management of these conditions are discussed in individual sections.
FAU - Jacob, Aasems
AU  - Jacob A
AUID- ORCID: http://orcid.org/0000-0002-7783-3786
AD  - Monmouth Medical Center, 300, 2nd Ave, Long Branch, NJ, 07740, USA.
      [email protected]
FAU - Thyagarajan, Bragadheeswar
AU  - Thyagarajan B
AD  - Wake Forest Baptist Medical Center, Winston Salem, NC, USA.
FAU - Kumar, Monisha Priyadarshini
AU  - Kumar MP
AD  - Akron General Medical Center, Akron, OH, USA.
FAU - Shaikh, Nasreen
AU  - Shaikh N
AD  - Monmouth Medical Center, 300, 2nd Ave, Long Branch, NJ, 07740, USA.
FAU - Sharon, David
AU  - Sharon D
AD  - Monmouth Medical Center, 300, 2nd Ave, Long Branch, NJ, 07740, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20171218
PL  - Germany
TA  - J Cancer Res Clin Oncol
JT  - Journal of cancer research and clinical oncology
JID - 7902060
SB  - IM
MH  - Cardiovascular Diseases/diagnosis/*etiology/physiopathology/therapy
MH  - Hodgkin Disease/*complications/diagnosis/physiopathology/therapy
MH  - Humans
OTO - NOTNLM
OT  - Cancer
OT  - Cardiac
OT  - Cardiology
OT  - Cardiovascular
OT  - Chemotherapy
OT  - Complications
OT  - Hodgkin's lymphoma
OT  - Lymphoma
OT  - Malignancy
OT  - Radiation
OT  - Treatment
EDAT- 2017/12/20 06:00
MHDA- 2018/01/10 06:00
CRDT- 2017/12/20 06:00
PHST- 2017/09/24 00:00 [received]
PHST- 2017/12/11 00:00 [accepted]
PHST- 2017/12/20 06:00 [pubmed]
PHST- 2018/01/10 06:00 [medline]
PHST- 2017/12/20 06:00 [entrez]
AID - 10.1007/s00432-017-2560-x [doi]
AID - 10.1007/s00432-017-2560-x [pii]
PST - ppublish
SO  - J Cancer Res Clin Oncol. 2018 Jan;144(1):99-107. doi: 10.1007/s00432-017-2560-x. 
      Epub 2017 Dec 18.